Share on StockTwits

Equities researchers at Leerink Swann started coverage on shares of Roka Bioscience (NASDAQ:ROKA) in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $13.00 price target on the stock. Leerink Swann’s price target would suggest a potential upside of 23.93% from the company’s current price.

Shares of Roka Bioscience (NASDAQ:ROKA) traded up 1.05% during mid-day trading on Monday, hitting $10.60. The stock had a trading volume of 42,420 shares. Roka Bioscience has a one year low of $9.15 and a one year high of $13.00. The stock has a 50-day moving average of $10. and a 200-day moving average of $10.. The company’s market cap is $186.9 million.

Roka Bioscience (NASDAQ:ROKA) last released its earnings data on Monday, August 11th. The company reported ($11.28) earnings per share for the quarter. The company had revenue of $1.40 million for the quarter.

Roka Bioscience, Inc is a molecular diagnostics company. The Company focuses on advanced testing solutions for the detection of foodborne pathogens.

The Fly On The Wall

Receive News & Ratings for Roka Bioscience Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.